Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19083426
Conclusion of this study
However, this reduction was not significant at 12th week. After 12 weeks of supplementation, Pycnogenol resulted in improved diabetes control, lowered CVD risk factors, and reduced antihypertensive medicine use vs controls.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Cardiovascular System |
